Lectura recomendada:
Ácido Bempedoico. Mecanismo de Acción y Propiedades Farmacocinéticas y Farmacodinámicas
Clínica e Investigación en Arteriosclerosis, 33(Supl 1):53-57
Lectura recomendada:
Temporal Haemodynamic Changes After Bisoprolol Treatment in Patients with Uncontrolled Hypertension
Annals of Translational Medicine, 9(11):1-11
Lectura recomendada:
Documento de Consenso sobre el uso de Sacubitrilo/Valsartán en Pacientes con Insuficiencia Cardiaca: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) de la Sociedad Interamericana de Cardiología (SIAC)
Archivos de Cardiología de México, 93(Supl):1-12
Lectura recomendada:
Efficacy and Safety of Givosiran for Acute Hepatic Porphyria: Final Results of the Randomized Phase III ENVISION Trial
Journal of Hepatology, 79(5):1150-1158
Lectura recomendada:
Investigating how Tamsulosin Combined with Levofloxacin Impacts Wound Healing in Patients with Chronic Prostatitis who May Also Have Perineal or Urethral Wounds
International Wound Journal, 21(1):1-8
Lectura recomendada:
Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study
The Journal of Clinical Psychiatry, 84(4):1-19
Lectura recomendada:
Effectiveness of Lipid-lowering Therapy on Mortality and Major Adverse Cardiovascular Event Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomised Controlled Trials
BMJ Open, 13(11):1-12
Lectura recomendada:
Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: a Pooled Analysis of 1201 Population-representative Studies with 104 Million Participants
The Lancet, 398(10304):957-980
Lectura recomendada:
Dual Therapy of Rifaximin and Lactulose Potentially Reduces Risk in Hepatic Encephalopathy
Cochrane Database Systematic Reviews,
¿Cuáles son los efectos del tratamiento con finerenona en pacientes con enfermedad renal y diabetes tipo 2?
Introducción:
En pacientes con diabetes tipo 2, la enfermedad renal crónica exacerba el riesgo de eventos cardiovasculares. El riesgo de eventos cardiovasculares y la incidencia de insuficiencia cardíaca aumentan cuando el cociente urinario de albúmina y creatinina es superior a 10, y cuando el índice de filtrado glomerular disminuye por debajo de 75 ml/min/1.73 m2.
Lectura recomendada:
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
New England Journal of Medicine, 385:2252-2263
Lectura recomendada:
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in
High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter,
Diabetes & Metabolism Journal, 47(6):818-825
Lectura recomendada:
Recovery of kidney Function after Dialysis Initiation in Children and Adults in the US: A Retrospective Study of United States Renal Data System data
PLoS Medicine, 18(2):1-16